Notice of Change to Research Objectives of RFA-AI-14-019 “Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens (R01)”

Notice Number: NOT-AI-14-044

Key Dates
Release Date: March 27, 2014

Related Announcements
RFA-AI-14-019

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

This Notice is to inform potential applicants that the NIAID is revising RFA-AI-14-019, “Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens (R01),” to clarify the Research Objectives section of the FOA.

The following correction to this FOA is being made:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Research Objectives

OLD LANGUAGE:
The proposed diagnostic technologies must detect the target pathogen(s) from at least one normally sterile specimen type, such as blood, CSF, or pleural fluid.

NEW LANGUAGE:
The proposed diagnostic technologies must detect the target pathogen(s) from at least one normally sterile specimen type, such as blood, urine, CSF, or pleural fluid.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Maureen Beanan, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-292-0999
Email: beananm@mail.nih.gov

 

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.